Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal

FEBRUARY 12, 2020

Pharmatest appoints new CEO

Pharmatest Services is pleased to announce that Dr. Jukka Rissanen will join the company as the new CEO starting on March 1st, 2020. Jukka brings extensive business and multidisciplinary scientific experience to the company.

Jukka has over 20 years of experience in various challenging roles within the pharmaceutical industry and has a long history with Pharmatest being the company’s COO for many years. Most recently he has been CEO and co-founder at PreclinApps Ltd, a medical technology company focused on drug delivery technologies.

In his new position as CEO, he will focus on the strategic growth of the business and delivering real value to customers. Chairman of the Board of Pharmatest, Mika Ali-Rantala: “We are delighted that Jukka is joining the company as the new CEO. We look forward to his leadership and knowledge supporting the continued growth of Pharmatest.”